Much is being said about the steady and dramatic decline in applications to nephrology training programs. The recent match shows a continuation of this trend: 67.9 percent of offered positions filled, leaving 50% of US programs unfilled on…
This month’s CJASN e-journal club was hosted at the Department of Nephrology at the Royal Infirmary of Edinburgh. It discussed a trial designed to investigate the efficacy of an intensive low salt diet intervention (weekly 30 minutes phone feedback…
The Nephrology twitter journal club will come to life on Saturday 15th November at Kidney Week in Philadelphia. NephJC co-founders Dr Joel Topf and Dr Swapnil Hiremath will co-host the event at the Double Tree hotel. There will…
Two ASN-related activities to mention happening in the next couple of months. First, CJASN eJC will be hosting a twitter conversation about the recently published commentary “Training the Next Generation’s Nephrology Workforce. This will be hosted by Amar…
The next Nephrology online journal club (#NephJC) will discuss the results of the CORONARY Trial, presented at the late breaking session at the ASN and published this year in JAMA. The trial compared patients undergoing their first coronary…
A bit of housekeeping here – I noticed that all of our current course announcements were out of date. These have now been updated with the most recent versions of each course including the following courses coming up…
The next Nephrology Twitter Journal Club (@NephJC) will discuss the POSEIDON Trial which has been published in The Lancet. Interest in the prevention of Contrast Induced Nephropathy (CIN) is alive and well with several novel approaches/therapies being recently…
Tomorrow night will be the 4th edition of the Nephrology Journal Club on twitter.The article this week is unusual – it is a clinical practice guideline for the management of hyponatremia that was published in NDT, the European…
The next Nephrology Twitter Journal Club (@NephJC) will discuss a study in JASN describing the use of Atrasentan, a selective Endothelin-A receptor blocker, in diabetic kidney disease. This is the latest attempt to resurrect this class of agents…
The inaugural Nephrology Twitter Journal Club kicks off tomorrow evening, that’s Tuesday April 29th, at 9pm Eastern time. The article being discussed concerns the implementation of a kidney disease screening and education program and its impact on ESRD…
